Financhill
Back

Xenon Pharmaceuticals 10K Form

Buy
69

XENE
Xenon Pharmaceuticals

Last Price:
47.16
Seasonality Move:
1%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive XENE News And Ratings

See the #1 stock for the next 7 days that we like better than XENE

XENE Financial Statistics

Sales & Book Value

Annual Sales: $9.43M
Cash Flow: $-43.43M
Price / Cash Flow: 0
Annual Sales: $9.79
Price / Book: 5.86

Profitability

EPS (TTM): -2.65000
Net Income (TTM): $-175.05M
Gross Margin: $6.83M
Return on Equity: 0%
Return on Assets: 0%

Xenon Pharmaceuticals Earnings Forecast

Key Xenon Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 7 years for XENE is 100.01%.
  • The Selling, General & Administrative Expenses for XENE have been equal to 347.78% of Gross Profit Margin.
  • The Research & Development expenses have been 1,121.13% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of XENE is -1,328.95% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

Xenon Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: XENE
CUSIP: 98420N
Website: xenon-pharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

XENE Technical Analysis vs Fundamental Analysis

Buy
69
Xenon Pharmaceuticals (XENE) is a Buy

Is Xenon Pharmaceuticals a Buy or a Sell?